Kaitlyn Reiff
Primary Care · West Long Branch, NJNPI 1285181644
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,137, more than ten times the $82 reported in 2021.
Across 111 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$310
- Biogen$275
- AstraZeneca$219
- ANI Pharmaceuticals, Inc.$179
- Eisai Inc.$111
- Lilly USA, LLC$104
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,233100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 13 | $310 |
| Biogen | 14 | $275 |
| AstraZeneca(2 entities) | 7 | $219 |
| ANI Pharmaceuticals, Inc. | 10 | $179 |
| Eisai Inc. | 7 | $111 |
| Lilly USA, LLC | 6 | $104 |
| Silk Road Medical, Inc. | 1 | $88 |
| AbbVie | 5 | $87 |
| Neurocrine Biosciences, Inc. | 4 | $78 |
| Aucta Pharmaceuticals, Inc. | 4 | $59 |
| Teva Pharmaceuticals USA, Inc. | 4 | $59 |
| Lundbeck LLC | 3 | $53 |
| Acadia Pharmaceuticals Inc | 3 | $52 |
| Pfizer | 3 | $52 |
| UCB, Inc. | 3 | $51 |
| Argenx US, Inc. | 3 | $49 |
| CSL Behring | 2 | $47 |
| Servier Pharmaceuticals LLC | 3 | $47 |
| SK Life Science, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Novartis | 1 | $32 |
| Medtronic | 1 | $29 |
| Springworks Therapeutics, Inc. | 1 | $20 |
| Merz Pharmaceuticals, LLC | 1 | $19 |
| Merck | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Amylyx Pharmaceuticals, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Octapharma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$125
How this compares
$2,233 in reported general payments places this provider in the 80th percentile of 330 primary care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other primary care in West Long Branch
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
- Anna NievesBasking Ridge$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.